Hypothyroidism is a common endocrine disorder characterized by insufficient production of thyroid hormones. The primary thyroid hormones, thyroxine (T4) and triiodothyronine (T3), play a critical role in regulating metabolism, energy production, and maintaining overall physiological balance. When levels of these hormones decrease, bodily systems slow down, leading to various symptoms that can significantly impact quality of life. The recognition and management of hypothyroidism are of great importance not only for maintaining systemic health but also for optimizing perioperative care.

Causes and Risk Factors
Hypothyroidism can develop for various reasons:
- Autoimmune thyroiditis (Hashimoto’s disease): The most common cause in iodine-sufficient regions.
- Iatrogenic causes: Following thyroid surgery or radioactive iodine therapy (when the thyroid gland is removed completely or almost completely).
- Medications: Certain drugs such as lithium, amiodarone, and interferon-alpha.
- Congenital hypothyroidism: Detected through newborn screening programs.
- Iodine deficiency or excess: Still prevalent in some regions.
Risk factors include female sex, age over 60, history of thyroid disease, thyroid surgery, or radiation exposure.
Clinical Manifestations
Symptoms typically develop slowly and may be difficult to recognize in the early stages. Common signs and symptoms include:
- Fatigue and weakness
- Weight gain despite decreased appetite
- Cold intolerance
- Constipation
- Dry skin and hair loss
- Menstrual irregularities
- Depression or mental slowing
- Bradycardia and hypotension in severe cases
In surgical patients, undiagnosed hypothyroidism can lead to delayed wound healing, increased sensitivity to anesthetic agents, and altered drug metabolism.
Diagnosis
Diagnosis is based on laboratory testing:
- TSH (Thyroid-Stimulating Hormone): Elevated in primary hypothyroidism.
- Free T4: Typically reduced.
- Anti-TPO antibodies: May be positive in autoimmune thyroiditis.
Subclinical hypothyroidism (elevated TSH with normal T4) should be monitored closely, especially in patients with cardiovascular risk or those scheduled for surgery.
Treatment and Management
The cornerstone of treatment is levothyroxine replacement therapy. Dosage is individualized based on age, weight, comorbidities, and TSH level.
- Follow-up: TSH levels should be monitored every 6–8 weeks during dose adjustment, and once stable, every 6–12 months.
- Special considerations: Dose adjustments may be required during pregnancy, illness, or significant weight changes.
Patient education is crucial—emphasizing the importance of regular medication use, awareness of interactions with substances like calcium or iron, and the need for routine follow-up.
Surgical Considerations
From a general surgery perspective, hypothyroidism poses specific challenges:
- Preoperative evaluation: Elective surgeries should be delayed until a euthyroid state is achieved.
- Anesthetic sensitivity: Patients may exhibit exaggerated responses to anesthetic agents.
- Postoperative recovery: Slowed metabolism can impair wound healing and prolong recovery.
Collaboration with endocrinology specialists can improve outcomes, particularly in complex or high-risk cases.
Conclusion
Hypothyroidism is a systemic but manageable condition. In surgical patients, early diagnosis and appropriate treatment significantly improve perioperative safety and long-term health. As part of a patient-centered approach, incorporating thyroid screening into routine evaluations—especially for individuals with nonspecific symptoms—enables timely diagnosis and better outcomes.
Contact
Feel free to reach out for a second opinion or to schedule an appointment.
You’re welcome to contact us directly with any questions you may have about diagnosis, treatment, or surgical procedures.
